Researchers at the University of Cologne and University Hospital Cologne have determined that the novel mRNA-based COVID-19 vaccines not only induce acquired immune responses such as antibody production, but also cause persistent ...
Mar 26, 2025
0
122
Sugar coatings aren't only for candies; they also help viruses, like the ones that cause COVID-19, hide from their hosts' immune system. Now, researchers have developed a universal vaccine that targets coronaviruses and the ...
Mar 25, 2025
0
180
An unusual public health policy in Wales may have produced the strongest evidence yet that a vaccine can reduce the risk of dementia. In a new study led by Stanford Medicine, researchers analyzing the health records of Welsh ...
Apr 2, 2025
0
110
Health experts are warning that whooping cough, also known as pertussis, is making a dangerous comeback.
Apr 3, 2025
0
18
Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 health care workers in Catalonia who were followed for three years. The study, led by ISGlobal ...
Apr 8, 2025
0
4
Immunization programs save millions of lives every year by protecting against preventable diseases. The immune response to vaccines, however, varies significantly between individuals, and the results can be suboptimal in ...
A vaccine to fight dementia? It turns out there may already be one—shots that prevent painful shingles also appear to protect aging brains.
Apr 6, 2025
0
11
Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the introduction of vaccines in the 1940s. In the decades since, the bacterial disease was nearly eradicated in ...
Apr 5, 2025
0
55
The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for Virology, Vaccinology and Therapeutics (CVVT) have pioneered an influenza virus vector-based nasal spray ...
Apr 3, 2025
0
31
Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides effective protection against respiratory syncytial virus-related lower respiratory tract disease (RSV-LRTD) ...
